These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35672283)

  • 21. Validated ligand binding sites in CCK receptors. next step: computer-aided design of novel CCK ligands.
    Tikhonova IG; Marco E; Lahlou-Archer E; Langer I; Foucaud M; Maigret B; Fourmy D
    Curr Top Med Chem; 2007; 7(12):1243-7. PubMed ID: 17584146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents.
    Trevaskis JL; Sun C; Athanacio J; D'Souza L; Samant M; Tatarkiewicz K; Griffin PS; Wittmer C; Wang Y; Teng CH; Forood B; Parkes DG; Roth JD
    Diabetes Obes Metab; 2015 Jan; 17(1):61-73. PubMed ID: 25204356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiolabeled gastrin/CCK analogs in tumor diagnosis: towards higher stability and improved tumor targeting.
    Kaloudi A; Nock BA; Krenning EP; Maina T; De Jong M
    Q J Nucl Med Mol Imaging; 2015 Sep; 59(3):287-302. PubMed ID: 26158215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonsulfated cholecystokinins in the small intestine of pigs and rats.
    Agersnap M; Rehfeld JF
    Peptides; 2015 Sep; 71():121-7. PubMed ID: 26206288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biology of gut cholecystokinin and gastrin receptors.
    Shulkes A; Baldwin GS
    Clin Exp Pharmacol Physiol; 1997; 24(3-4):209-16. PubMed ID: 9131287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholecystokinin receptors in Atlantic salmon: molecular cloning, gene expression, and structural basis.
    Rathore RM; Angotzi AR; Jordal AE; Rønnestad I
    Physiol Rep; 2013 Oct; 1(5):e00069. PubMed ID: 24303160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type 1 Cholecystokinin Receptor. Possible Cooperativity across the Receptor Homodimeric Complex.
    Desai AJ; Lam PC; Orry A; Abagyan R; Christopoulos A; Sexton PM; Miller LJ
    J Med Chem; 2015 Dec; 58(24):9562-77. PubMed ID: 26654202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural insights into the human D1 and D2 dopamine receptor signaling complexes.
    Zhuang Y; Xu P; Mao C; Wang L; Krumm B; Zhou XE; Huang S; Liu H; Cheng X; Huang XP; Shen DD; Xu T; Liu YF; Wang Y; Guo J; Jiang Y; Jiang H; Melcher K; Roth BL; Zhang Y; Zhang C; Xu HE
    Cell; 2021 Feb; 184(4):931-942.e18. PubMed ID: 33571431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterodimerization of cholecystokinin 1 and cholecystokinin 2 receptors in gallbladder cancer: a new mechanism for carcinogenesis.
    Nigam J; Kazmi HR; Khare L; Srivastava M; Chandra A
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7069-7078. PubMed ID: 36871090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations within the cholecystokinin-B/gastrin receptor ligand 'pocket' interconvert the functions of nonpeptide agonists and antagonists.
    Bläker M; Ren Y; Gordon MC; Hsu JE; Beinborn M; Kopin AS
    Mol Pharmacol; 1998 Nov; 54(5):857-63. PubMed ID: 9804620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterisation of the effects of SR146131, a novel non-peptide CCK(1) receptor agonist, on IMR-32 human neuroblastoma cells.
    Schaeffer P; Nestor AL; Prabonnaud V; Bachy A; Laplace MC; Keane PE; Bignon E; Herbert JM
    Eur J Pharmacol; 2000 Jun; 397(2-3):303-10. PubMed ID: 10844128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SR146131, a cholecystokinin-A receptor agonist, antagonizes prepulse inhibition deficits produced by dizocilpine and DOI.
    Shilling PD; Feifel D
    Psychopharmacology (Berl); 2002 Nov; 164(3):285-93. PubMed ID: 12424552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of membrane cholecystokinin-2 receptor by agonists enables classification of partial agonists as biased agonists.
    Magnan R; Masri B; Escrieut C; Foucaud M; Cordelier P; Fourmy D
    J Biol Chem; 2011 Feb; 286(8):6707-19. PubMed ID: 21156802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of cholecystokinin receptors in colon cancer and the clinical correlation in Taiwan.
    Huang BP; Lin CH; Chen YC; Kao SH
    Tumour Biol; 2016 Apr; 37(4):4579-84. PubMed ID: 26508021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of cholecystokinin-B/gastrin receptor domains that confer high gastrin affinity: utilization of a novel Xenopus laevis cholecystokinin receptor.
    Schmitz F; Pratt DS; Wu MJ; Kolakowski LF; Beinborn M; Kopin AS
    Mol Pharmacol; 1996 Aug; 50(2):436-41. PubMed ID: 8700154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial effects of β-sitosterol on type 1 cholecystokinin receptor dysfunction induced by elevated membrane cholesterol.
    Desai AJ; Dong M; Miller LJ
    Clin Nutr; 2016 Dec; 35(6):1374-1379. PubMed ID: 27016394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting of a CCK(2) receptor splice variant with (111)In-labelled cholecystokinin-8 (CCK8) and (111)In-labelled minigastrin.
    Laverman P; Roosenburg S; Gotthardt M; Park J; Oyen WJ; de Jong M; Hellmich MR; Rutjes FP; van Delft FL; Boerman OC
    Eur J Nucl Med Mol Imaging; 2008 Feb; 35(2):386-92. PubMed ID: 17934729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanism underlying partial and full agonism mediated by the human cholecystokinin-1 receptor.
    Archer-Lahlou E; Escrieut C; Clerc P; Martinez J; Moroder L; Logsdon C; Kopin A; Seva C; Dufresne M; Pradayrol L; Maigret B; Fourmy D
    J Biol Chem; 2005 Mar; 280(11):10664-74. PubMed ID: 15632187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategies for design of non peptide CCK1R agonist/antagonist ligands.
    García-López MT; González-Muñiz R; Martín-Martínez M; Herranz R
    Curr Top Med Chem; 2007; 7(12):1180-94. PubMed ID: 17584140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.